Markets:

Overview

News

Currencies

International

Treasuries

Greenwich LifeSciences, Inc. - Common stock (NQ:GLSI)

24.06 -0.87 (-3.49%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Greenwich LifeSciences, Inc. - Common stock

< Previous 1 2 3 Next >

5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More ↗

September 19, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week...

Via Benzinga

ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week ↗

September 12, 2022

We're starting off another week with a deep dive into the short squeeze stocks traders are going to want to keep an eye on!

Via InvestorPlace

10 Short Squeeze Candidates That May Soar: Athersys, TDH Holdings, FaZe Holdings, Weber And More ↗

September 12, 2022

Via Benzinga

MICS, REV: The Top 5 Short Squeeze Stocks to Watch This Week ↗

August 22, 2022

Investors looking for the most likely short squeeze stocks to watch this week are in the right place with a list of the top five to watch!

Via InvestorPlace

Revlon Climbs, Singing Machine Moves Up And Weber Makes Big Move: 5 Short Squeeze Stocks That May Soar This Week ↗

August 22, 2022

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.

Via Benzinga

7 Short-Term Stocks to Buy for a Quick Profit ↗

August 08, 2022

Although the market has been volatile this year, the wildness also creates opportunities for short-term stocks to buy for a quick profit.

Via InvestorPlace

5 Short Squeeze Stocks That May Soar Plus 5 To Watch: ToughBuilt, Redbox, Revlon And More ↗

August 08, 2022

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.

Via Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket ↗

July 13, 2022

Gainers

Via Benzinga

Boeing, PriceSmart And 80 Biggest Movers From Yesterday ↗

July 13, 2022

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Via Benzinga

Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher ↗

July 12, 2022

U.S. stocks traded mixed toward the end of trading after recording losses in the previous session.

Via Benzinga

Here's Why Greenwich Lifesciences Shares Are Popping Off Today ↗

July 12, 2022

Greenwich Lifesciences Inc (NASDAQ: GLSI) shares are trading higher by 32.95% to $11.46 Tuesday afternoon after the FDA removed the clinical hold on the company's Flamingo-01 Phase 3 trial of GP2.

Via Benzinga

U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 Results ↗

July 12, 2022

U.S. stocks turned higher midway through trading after recording losses in the previous session.

Via Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session ↗

July 12, 2022

Gainers

Via Benzinga

Versus Systems (VS) Stock Roars After Nasdaq Warning ↗

July 12, 2022

Versus Systems (VS) stock is rising higher on Tuesday after getting a delisting warning from the Nasdaq Exchange about a month ago.

Via InvestorPlace

Why Is Greenwich Lifesciences (GLSI) Stock Up Today? ↗

July 12, 2022

Greenwich Lifesciences (GLSI) stock is heading higher on Tuesday after the FDA lifted a hold on a Phase III clinical trial.

Via InvestorPlace

Why Markets Are Trading Mixed; US Small Business Optimism Tumbles To This Level ↗

July 12, 2022

U.S. stocks traded mixed this morning after recording losses in the previous session.

Via Benzinga

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner ↗

July 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 28, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

69 Biggest Movers From Yesterday ↗

June 10, 2022

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.

Via Benzinga

Recession Fears are Creating a Golden Opportunity for Biotech Stocks ↗

April 08, 2022

Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 23, 2022

Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the...

Via Benzinga

78 Biggest Movers From Friday ↗

February 14, 2022

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...

Via Benzinga

3 Stocks Insiders Are Buying on Market Turbulence ↗

January 27, 2022

When insiders buy a stock, you should take it as a sign that they think good news is about to come out. Here are three to watch closely.

Via InvestorPlace

62 Biggest Movers From Yesterday ↗

February 11, 2022

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq....

Via Benzinga

Greenwich LifeSciences Reveals 5-Year Data for GP2 Immunotherapy In Breast Cancer Settings ↗

December 09, 2021

Greenwich LifeSciences Inc (NASDAQ: GLSI) has published new GP2 Phase 2b trial data. The trial enrolled HER2 positive patients, who received a standard course of...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

58 Biggest Movers From Friday ↗

December 06, 2021

Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Greenwich LifeSciences, Inc. - Common stock (NQ:GLSI)

Headline News about Greenwich LifeSciences, Inc. - Common stock

Starting at $3.75/week.

Subscribe Today